Hudson Global (HSON) Stock Forecast, Price & News

1 Wall Street equities research analysts have issued "buy," "hold," and "sell" ratings for Hudson Global in the last twelve months. There are currently 1 buy rating for the stock. The consensus among Wall Street equities research analysts is that investors should "buy" HSON shares.
View HSON analyst ratings or view top-rated stocks.

1 Wall Street analysts have issued twelve-month price targets for Hudson Global's shares. Their HSON share price forecasts range from $42.50 to $42.50. On average, they expect the company's stock price to reach $42.50 in the next twelve months. This suggests a possible upside of 90.9% from the stock's current price.
View analysts price targets for HSON or view top-rated stocks among Wall Street analysts.

Hudson Global's stock was trading at $22.63 at the start of the year. Since then, HSON stock has decreased by 1.6% and is now trading at $22.26.
View the best growth stocks for 2023 here.

The company is scheduled to release its next quarterly earnings announcement on Thursday, August 10th 2023.
View our HSON earnings forecast.

Hudson Global, Inc. (NASDAQ:HSON) announced its earnings results on Thursday, March, 30th. The business services provider reported $0.33 earnings per share (EPS) for the quarter, beating analysts' consensus estimates of $0.08 by $0.25. The business services provider had revenue of $43.59 million for the quarter, compared to analysts' expectations of $49.25 million. Hudson Global had a trailing twelve-month return on equity of 16.42% and a net margin of 2.40%.

5 employees have rated Hudson Global Chief Executive Officer Jeffrey Eberwein on Glassdoor.com. Jeffrey Eberwein has an approval rating of 55% among the company's employees. This puts Jeffrey Eberwein in the bottom 25% of approval ratings compared to other CEOs of publicly-traded companies.

Based on aggregate information from My MarketBeat watchlists, some companies that other Hudson Global investors own include International Business Machines (IBM), Pfizer (PFE), AT&T (T), Exxon Mobil (XOM), AbbVie (ABBV), BCE (BCE), Blackrock Resources & Commodities Strategy Trust (BCX), BlackRock Enhanced International Dividend Trust (BGY) and Cinemark (CNK).

Hudson Global trades on the NASDAQ under the ticker symbol "HSON."

Hudson Global's stock is owned by a variety of institutional and retail investors. Top institutional shareholders include Dimensional Fund Advisors LP (3.41%), Renaissance Technologies LLC (3.31%), HighTower Advisors LLC (3.27%), Jacob Asset Management of New York LLC (2.03%), Aristides Capital LLC (0.47%) and LSV Asset Management (0.25%). Insiders that own company stock include Daniel D Herink, Jeffrey E Eberwein and Jeffrey E Eberwein.
View institutional ownership trends.

Shares of HSON stock can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab.
Compare Top Brokerages Here.

One share of HSON stock can currently be purchased for approximately $22.26.

Hudson Global (NASDAQ:HSON) has a market capitalization of $63.22 million and generates $200.92 million in revenue each year. The business services provider earns $7.13 million in net income (profit) each year or $1.41 on an earnings per share basis.

The company employs 1,440 workers across the globe.

Hudson Global's mailing address is 53 FOREST AVENUE, OLD GREENWICH CT, 06870. The official website for the company is am.hudsonrpo.com. The business services provider can be reached via phone at (475) 988-2068, via email at ir@hudsonrpo.com, or via fax at 212-351-7401.